Clinical Trial Update: Sildenafil for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sildenafil for cerebrovascular dysfunction in chronic traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-concussive Syndrome
• Traumatic Brain Injury

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Uniformed Services University of the Health Sciences | Conditions: Traumatic Brain Injury, Post-concussive Syndrome | Phase 2 | Status: COMPLETED